The progesterone receptor A (PR-A) is one of three known isoforms of the progesterone receptor (PR), the main biological target of the endogenous progestogen sex hormone progesterone.[1][2] The other isoforms of the PR include the PR-B and PR-C.[1][2]
PR-A is 164 residues shorter than PR-B in humans[3] and anywhere from 128-165 residues shorter in other organisms.[4] Each isoform binds its natural ligand, progesterone, but also demonstrates the ability to bind a number of other agonists including norethindrone, a synthetic progestin.[5]
Expression and overexpression
PR-A and PR-B are generally expressed in equal ratios,[3] but PR-A is expressed in larger amounts in uterine stromal cells normally.[6] A spike in PR-A expression in the myometrium has been observed to initiate parturition in placental mammals.[7]
PR-A is the isoform most commonly observed to be overexpressed in human breast cancer. Currently PR is estimated by immunohistochemistry and earlier was quantified by standardized radio-ligand binding assays developed by New England Nuclear and Wittliff.[8] Patients with PR-A rich carcinomas, as opposed to patients with PR-B rich carcinomas, have faster recurrence rates.[9]
See also
References
- ^ a b Jacobsen BM, Horwitz KB (2012). "Progesterone receptors, their isoforms and progesterone regulated transcription". Mol. Cell. Endocrinol. 357 (1–2): 18–29. doi:10.1016/j.mce.2011.09.016. PMC 3272316. PMID 21952082.
- ^ a b Scarpin KM, Graham JD, Mote PA, Clarke CL (2009). "Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression". Nucl Recept Signal. 7: e009. doi:10.1621/nrs.07009. PMC 2807635. PMID 20087430.
- ^ a b Graham, J Dinny; Clarke, Christine L (October 2002). "Progesterone receptors - animal models and cell signaling in breast cancer: Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells". Breast Cancer Research. 4 (5): 187–190. doi:10.1186/bcr450. ISSN 1465-542X. PMC 138742. PMID 12223122.
- ^ Conneely, O (November 2000). "Progesterone receptors in reproduction: functional impact of the A and B isoforms". Steroids. 65 (10–11): 571–577. doi:10.1016/S0039-128X(00)00115-X. PMID 11108861.
- ^ Madauss, Kevin P.; Deng, Su-Jun; Austin, Robert J. H.; Lambert, Millard H.; McLay, Iain; Pritchard, John; Short, Steven A.; Stewart, Eugene L.; Uings, Ian J.; Williams, Shawn P. (2004-06-01). "Progesterone Receptor Ligand Binding Pocket Flexibility: Crystal Structures of the Norethindrone and Mometasone Furoate Complexes". Journal of Medicinal Chemistry. 47 (13): 3381–3387. doi:10.1021/jm030640n. ISSN 0022-2623. PMID 15189034.
- ^ Bulun, Serdar E.; Cheng, You-Hong; Yin, Ping; Imir, Gonca; Utsunomiya, Hiroki; Attar, Erkut; Innes, Joy; Julie Kim, J. (March 2006). "Progesterone resistance in endometriosis: Link to failure to metabolize estradiol". Molecular and Cellular Endocrinology. 248 (1–2): 94–103. doi:10.1016/j.mce.2005.11.041. PMID 16406281.
- ^ Cope, Dominique; Monsivais, Diana (2022-04-27). "Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success". Cells. 11 (9): 1474. doi:10.3390/cells11091474. ISSN 2073-4409. PMC 9104461. PMID 35563781.
- ^ Fisher, B., Redmond, C., Brown, A., Wickerham, D. L., Wolmark, N., Allegra, J. C., Escher, G., Lippman, M., Savlov, E., Wittliff, J. L. and Fisher, E. R. et al. Influence of Tumor Estrogen and Progesterone Receptor Levels on the Response to Tamoxifen and Chemotherapy in Primary Breast Cancer. J. Clin. Oncol., 1:227-241, 1983. https://pubmed.ncbi.nlm.nih.gov/6366135/
- ^ Timmermans-Sprang, Elpetra P. M.; Gracanin, Ana; Mol, Jan A. (2017-04-13). "Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification". Frontiers in Veterinary Science. 4: 53. doi:10.3389/fvets.2017.00053. ISSN 2297-1769. PMC 5389977. PMID 28451590.
|
---|
(1) Basic domains |
---|
(1.1) Basic leucine zipper (bZIP) | |
---|
(1.2) Basic helix-loop-helix (bHLH) | Group A | |
---|
Group B | |
---|
Group C bHLH-PAS | |
---|
Group D | |
---|
Group E | |
---|
Group F bHLH-COE | |
---|
|
---|
(1.3) bHLH-ZIP | |
---|
(1.4) NF-1 | |
---|
(1.5) RF-X | |
---|
(1.6) Basic helix-span-helix (bHSH) | |
---|
|
|
(2) Zinc finger DNA-binding domains |
---|
(2.1) Nuclear receptor (Cys4) | subfamily 1 | |
---|
subfamily 2 | |
---|
subfamily 3 | |
---|
subfamily 4 | |
---|
subfamily 5 | |
---|
subfamily 6 | |
---|
subfamily 0 | |
---|
|
---|
(2.2) Other Cys4 | |
---|
(2.3) Cys2His2 | |
---|
(2.4) Cys6 | |
---|
(2.5) Alternating composition | |
---|
(2.6) WRKY | |
---|
|
|
|
(4) β-Scaffold factors with minor groove contacts |
---|
|
|
(0) Other transcription factors |
---|
|
|
see also transcription factor/coregulator deficiencies |
|
---|
PRTooltip Progesterone receptor | Agonists |
- Retroprogesterone derivatives: 20α-Dihydrodydrogesterone
- 20α-Dihydrotrengestone
- DU-41164
- DU-41165
- Dydrogesterone
- Retroprogesterone
- Ro 6-3129
- Trengestone
- 17α-Substituted progesterone derivatives: 6α-Methyl-17α-bromoprogesterone
- 15β-Hydroxycyproterone acetate
- 16-Methylene-17α-hydroxyprogesterone acetate
- 17α-Bromoprogesterone
- 17α-Hydroxyprogesterone (hydroxyprogesterone)
- 17α-Methylprogesterone
- Acetomepregenol (mepregenol diacetate)
- Algestone
- Algestone acetonide
- Algestone acetophenide
- Anagestone
- Anagestone acetate
- Bromethenmadinone
- Bromethenmadinone acetate
- Butagest (buterol)
- Chlormadinone
- Chlormadinone acetate
- Chlormadinone caproate
- Chlormethenmadinone
- Chlormethenmadinone acetate
- Cismadinone
- Cismadinone acetate
- Clogestone
- Clogestone acetate
- Clomegestone
- Clomegestone acetate
- Cymegesolate
- Cyproterone acetate
- Delmadinone
- Delmadinone acetate
- Edogestrone
- Flugestone
- Flugestone acetate
- Fluorometholone
- Fluorometholone acetate
- Flumedroxone
- Flumedroxone acetate
- Fluoromedroxyprogesterone acetate
- Gestaclone
- Gestobutanoyl
- Haloprogesterone
- Hydromadinone
- Hydromadinone acetate
- Hydroxyprogesterone acetate
- Hydroxyprogesterone caproate (hydroxyprogesterone hexanoate)
- Hydroxyprogesterone heptanoate (hydroxyprogesterone enanthate)
- Hydroxyprogesterone heptanoate benzilic acid hydrazone
- Mecigestone (pentarane B)
- Medrogestone
- Medroxyprogesterone
- Medroxyprogesterone acetate
- Medroxyprogesterone caproate
- Megestrol
- Megestrol acetate
- Megestrol caproate
- Melengestrol
- Melengestrol acetate
- Methenmadinone
- Methenmadinone acetate
- Methenmadinone caproate
- Mometasone
- Mometasone furoate
- Osaterone
- Osaterone acetate
- Pentagestrone
- Pentagestrone acetate
- Pentarane A
- Proligestone
- Triamcinolone acetonide
- 19-Norprogesterone derivatives: 17α-Methyl-19-norprogesterone
- 18-Methylsegesterone acetate
- 19-Norprogesterone
- Amadinone
- Amadinone acetate
- Demegestone
- Fluoro ethyl norprogesterone
- Fluoro furanyl norprogesterone
- Gestadienol
- Gestadienol acetate
- Gestonorone acetate (gestronol acetate)
- Gestonorone caproate (gestronol hexanoate)
- Gestronol (gestonorone)
- Nomegestrol
- Nomegestrol acetate
- Norgestomet
- ORG-2058
- Oxogestone
- Oxogestone phenpropionate (xinogestone)
- Promegestone
- Segesterone
- Segesterone acetate (nestorone)
- Trimegestone
- Testosterone derivatives: Progestins: 6,6-Difluoronorethisterone
- 6,6-Difluoronorethisterone acetate
- 17α-Allyl-19-nortestosterone
- Allylestrenol
- Altrenogest
- Chloroethynylnorgestrel
- Cingestol
- Danazol
- Desogestrel
- Dienogest
- Ethinylandrostenediol
- Ethisterone
- Ethynerone
- Etonogestrel
- Etynodiol
- Etynodiol diacetate
- Gestodene
- Gestrinone
- Levonorgestrel
- Levonorgestrel esters (e.g., levonorgestrel butanoate)
- Lynestrenol
- Lynestrenol phenylpropionate
- Metynodiol
- Metynodiol diacetate
- Norelgestromin
- Norethisterone (norethindrone)
- Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)
- Noretynodrel
- Norgesterone
- Norgestimate
- Norgestrel
- Norgestrienone
- Norvinisterone
- Oxendolone
- Quingestanol
- Quingestanol acetate
- Tibolone
- Tigestol
- Tosagestin; Anabolic–androgenic steroids: 11β-Methyl-19-nortestosterone
- 11β-Methyl-19-nortestosterone dodecylcarbonate
- 19-Nor-5-androstenediol
- 19-Nor-5-androstenedione
- 19-Nordehydroepiandrosterone
- Bolandiol
- Bolandiol dipropionate
- Bolandione
- Dimethisterone
- Dienedione
- Dienolone
- Dimethandrolone
- Dimethandrolone buciclate
- Dimethandrolone dodecylcarbonate
- Dimethandrolone undecanoate
- Dimethyldienolone
- Dimethyltrienolone
- Ethyldienolone
- Ethylestrenol (ethylnandrol)
- Methyldienolone
- Metribolone (R-1881)
- Methoxydienone (methoxygonadiene)
- Mibolerone
- Nandrolone
- Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)
- Norethandrolone
- Normethandrone (methylestrenolone, normethandrolone, normethisterone)
- RU-2309
- Tetrahydrogestrinone
- Trenbolone (trienolone)
- Trenbolone esters (e.g., trenbolone acetate, trenbolone enanthate)
- Trendione
- Trestolone
- Trestolone acetate
- Spirolactone derivatives: Canrenoic acid
- Canrenone
- Drospirenone
- Mespirenone
- Potassium canrenoate
- Prorenone
- SC-5233 (spirolactone)
- SC-8109
- Spironolactone
- Spirorenone
- Nonsteroidal: 3,8-Dihydrodiligustilide
- LG-2527
- LG-100128
- Riligustilide
- RWJ-26819
- RWJ-49853
- RWJ-60130
- Tanaproget
- ZM-182345
- Unknown: ORG-47241
- ORG-201745
|
---|
Mixed (SPRMsTooltip Selective progesterone receptor modulators) |
- Steroidal: Dihydroethisterone
- 5α-Dihydrolevonorgestrel
- 5α-Dihydronorethisterone
- Asoprisnil
- Asoprisnil ecamate
- Guggulsterone
- J1042
- LG-120838
- Metapristone (RU-42633)
- Mifepristone (RU-486)
- ORF-9371
- ORF-9326
- ORG-31710
- ORG-33628
- RMI-12936
- Telapristone
- Ulipristal acetate
- Vilaprisan
- ZK-137316
- Nonsteroidal: Apigenin
- Kaempferol
- LG-120920
- Naringenin
- PRA-910
- Syringic acid
|
---|
Antagonists |
- Steroidal: Aglepristone
- Lilopristone
- Lonaprisan
- Onapristone
- ORG-31710
- ORG-31806
- ORG-33628
- RTI 3021–022
- Toripristone
- Zanoterone
- Nonsteroidal: Darolutamide
- LG-001447
- LG-100127
- LG-100128
- LG-120830
- LG-121046
- Valproic acid
- ZM-150271
- ZM-172406
|
---|
|
---|
mPRTooltip Membrane progesterone receptor (PAQRTooltip Progestin and adipoQ receptor) | |
---|
- See also
- Receptor/signaling modulators
- Progestogens and antiprogestogens
- Androgen receptor modulators
- Estrogen receptor modulators
- List of progestogens
|